Segments - Spinal Device Market by Product (Spinal Fusion Devices and Non-fusion Devices), Procedure Type (Discectomy, Laminotomy, Corpectomy, and Facetectomy), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Spinal Surgery Rehabilitation Centers), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024 – 2032
The global spinal device market size was USD 14.3 Billion in 2023 and is expected to reach USD 23.0 Billion by 2032, expanding at a CAGR of 5.4% during 2024–2032. The market growth is attributed to the rising prevalence of spinal disorders.
Spinal devices are medical instruments used to diagnose, treat, and stabilize various spinal conditions. These conditions range from common issues such as disc herniation to more complex problems such as scoliosis or spinal fractures. The global spinal device market is vast and constantly evolving, with advancements aiming to improve patient outcomes and treatment approaches.
The spinal device market is undergoing a revolution with advancements in minimally invasive surgery, allowing for fast recovery; the rise of motion-preserving technologies such as artificial discs to maintain natural movement; personalized medicine using AI for customized treatment plans and potentially even bespoke implants; biomaterials & regenerative medicine offering improved integration and natural disc repair possibilities; robotics, navigation systems with AI-powered surgical robots; and real-time guidance for enhanced surgical precision.
Increasing improvisation in the diagnostics and surgical planning is propelling the global market. AI algorithms analyze X-rays, MRIs, and CT scans with high accuracy, assisting doctors in identifying spinal issues, assessing severity, and planning surgical procedures precisely. Furthermore, the increasing development of personalized devices is driving the market significantly.
Rising prevalence of spinal disorders such as spondylosis, spinal stenosis, and other spinal injuries is expected to boost the market in the coming years. Furthermore, the increasing aging population is expected to drive the market. Additionally, the increasing technological advancements such as minimally invasive surgical techniques and advanced spinal implants is expected to fuel the market during the forecast period.
High cost of procedures and devices is expected to hinder the global market in the coming years. Spinal surgeries and the implants used in those surgeries are very expensive. This is a barrier for patients, especially in regions with limited healthcare coverage. Complexities in insurance coverage and reimbursement policies for spinal procedures and devices limit patient access and reduce market.
Personalized medicine and implants are expected to offer growth opportunities in the market in the coming years. Furthermore, the biomaterials and regenerative medicines are the latest advancements in the global market, which better integrate with the body and promote bone growth.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Spinal Device Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017–2022 |
Forecast Period |
2024–2032 |
Segmentation |
Product (Spinal Fusion Devices and Non-fusion Devices), Procedure Type (Discectomy, Laminotomy, Corpectomy, and Facetectomy), End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Spinal Surgery Rehabilitation Centers) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Aesculap, Inc.; Alphatec Spine, Inc.; DePuy Synthes; Globus Medical; Medtronic; NuVasive, Inc.; Siemens Healthcare GmbH; Stryker; Vertiflex, Inc.; and Zimmer Biomet, Inc. |
In terms of region, the global spinal device market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America dominates the global market in 2023, owing to the high prevalence of spinal disorders. Moreover, the advanced healthcare infrastructure is boosting the regional market. Additionally, the high healthcare spending and technological advancements is expected to fuel the regional market during the forecast period.
The market in Europe is projected to grow at a significant pace in the coming years, owing to the established healthcare systems. Countries in Europe generally have well-established healthcare systems with universal or near-universal coverage. This ensures a large patient pool with access to spinal surgeries and related devices.
On the basis of product, the global market is bifurcated into spinal fusion devices and non-fusion devices. The spinal fusion devices segment is anticipated to register a considerable CAGR in over the predicted period, owing to the established surgical technique. Spinal fusion surgery has been a well-established and proven procedure for a longer period as compared to non-fusion surgeries. Surgeons have extensive experience with this approach, making it a familiar and reliable option. Spinal fusion address various spinal issues such as instability, deformity, and pain caused by conditions such as spondylolisthesis, scoliosis, and degenerative disc disease.
The non-fusion devices segment is projected to register a robust growth rate during the assessment years, due to increasing demand for motion preservation in spinal surgeries. Non-fusion devices allow for more natural movement of the spine as compared to fusion procedures, which lead to improved long-term function and patient satisfaction.
On the basis of procedure type, the spinal device market is segmented into discectomy, laminotomy, corpectomy, and facetectomy. The discectomy segment registers a robust growth rate in 2023, due to the large prevalence of disc herniation. Disc herniation, where the soft inner disc material bulges and presses on a nerve, is a common cause of back and leg pain. Discectomy is the most common surgical treatment for this condition, driving the segment.
The laminotomy segment is expected to expand at a significant growth rate over the projection period. Laminotomy procedure creates space in the spinal canal by removing a portion of the lamina or foramina. This alleviates nerve compression caused by bone spurs, ligament thickening, or bulging discs, which are all reasons for spinal stenosis, a common cause of back pain and leg weakness.
Based on end-user, the spinal device market is divided into hospitals, clinics, ambulatory surgical centers, and spinal surgery rehabilitation centers. The hospitals segment held a large share in the global market in 2023, owing to the increasing number of complex procedures and advanced facilities in hospital settings. Hospitals are typically equipped to handle a wide range of complex spinal surgeries, including those requiring extensive monitoring, specialized equipment, and the presence of various specialists. Procedures such as corpectomy or complex deformity corrections are often performed in hospital settings.
The ambulatory surgical centers segment is anticipated to expand at a substantial CAGR during the forecast period, due to the growth of minimally invasive procedures. Advancements in technology and surgical techniques have led to a rise in minimally invasive spinal procedures such as discectomy, which is safely performed in ASCs.
The spinal device market has been segmented on the basis of
Key players competing in the global spinal device market are Aesculap, Inc.; Alphatec Spine, Inc.; DePuy Synthes; Globus Medical; Medtronic; NuVasive, Inc.; Siemens Healthcare GmbH; Stryker; Vertiflex, Inc.; and Zimmer Biomet, Inc.
These companies use development strategies including mergers, acquisitions, partnerships,
collaboration, and product launches to expand their consumer base across the globe.
In March 2021, Spine Wave announced the commercial launch of its latest innovation, the Stronghold 3D Titanium Interbody Device. This cutting-edge device is powered by the company's proprietary TiCell 3D advanced surface technology. This breakthrough advancement enables Spine Wave to expand its portfolio of lumbar interbody infusion products, further solidifying its position in the industry and complementing its existing range of innovative solutions.
In March 2021, Osseus Fusion Systems announced the official launch of its Aries-TC, a revolutionary 3D printing transforaminal curved interbody fusion device. This innovative device is part of the company's Aries 3D printed Lumbar Interbody product line, designed to meet the unique needs of skeletally strong patients suffering from degenerative disc disease. With the Aries-TC, Osseus Fusion Systems is expanding its offerings in the field of spinal fusion, providing a new solution for patients seeking effective treatment options.